Patent details

EP3233103 Title: TREATMENT OF PEMPHIGUS

Basic Information

Publication number:
EP3233103
PCT Application Number:
US2015066868
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP158231076
PCT Publication Number:
WO2016100914
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF PEMPHIGUS
French Title of Invention:
TRAITEMENT DE LE PEMPHIGUS
German Title of Invention:
BEHANDLUNG VON PEMPHIGUS
SPC Number:

Dates

Filing date:
18/12/2015
Grant date:
14/10/2020
EP Publication Date:
25/10/2017
PCT Publication Date:
23/06/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/10/2020
EP B1 Publication Date:
14/10/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/12/2020
Expiration date:
18/12/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/10/2020
 
 

Name:
Principia Biopharma Inc.
Address:
220 E. Grand Ave., S. San Francisco, CA 94080, United States (US)

Inventor

Name:
GOURLAY, Steven
Address:
Australia (AU)

Priority

Priority Number:
201462093891 P
Priority Date:
18/12/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4545; A61K 31/4985; A61K 31/505; A61K 31/519; A61K 38/00; A61K 45/06; A61P 29/00; A61P 37/00;

Publication

European Patent Bulletin

Issue number:
202042
Publication date:
14/10/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages